Sarah Katz Caffeine Safety Act

Summary

Requires restaurants in chains of 20 or more and packaged food and supplement labels to disclose caffeine amounts and, for high-caffeine restaurant items, an on-menu “High caffeine” statement or symbol. Orders FDA and NIH to complete safety reviews of caffeine and stimulant blends and to report to Congress within six months; funds each review at $1 million. Directs FDA to run a public education campaign about caffeine risks for vulnerable groups and asks GAO to study caffeine marketing to youth within 180 days.

• Chains with 20+ locations must label menu items with added caffeine ≥150 mg per serving with a 'High caffeine' statement or symbol and list caffeine milligrams.
• Packaged foods and dietary supplements with >10 mg caffeine per serving must list mg of caffeine, state if it is added or natural, and include an adult daily-limit advisory.
• FDA must review whether caffeine is GRAS, assess added-caffeine blends, and report publicly to Congress within six months.
• NIH must review caffeine and stimulants’ effects on vulnerable populations and report publicly to Congress within six months.
• HHS/FDA must run a public education campaign on safe caffeine use, focusing on children, pregnant people, heart conditions, seizure disorders, and marketing to youth.
• GAO must study caffeine marketing (including social media/influencers) with emphasis on marketing to children and teens and report within 180 days.
• The bill authorizes $1 million each for the FDA and NIH reviews but leaves many implementation details (definitions, rulemaking) to agencies.
• Labels, menu boards, and marketing practices in food service and packaged goods markets are likely to change to meet new disclosure and advisory requirements.